作者
William L Baker, Craig I Coleman, Jeffrey Kluger, Kurt M Reinhart, Ripple Talati, Robert Quercia, Olivia J Phung, C Michael White
发表日期
2009/12/15
来源
Annals of internal medicine
卷号
151
期号
12
页码范围
861-871
出版商
American College of Physicians
简介
Background
Patients with ischemic heart disease and preserved ventricular function experience considerable morbidity and mortality despite standard medical therapy.
Purpose
To compare benefits and harms of using angiotensin-converting enzyme (ACE) inhibitors, angiotensin II–receptor blockers (ARBs), or combination therapy in adults with stable ischemic heart disease and preserved ventricular function.
Data Sources
MEDLINE, EMBASE, Cochrane Central Register of Controlled Trials, and Cochrane Database of Systematic Reviews (earliest date, July 2009) were searched without language restrictions.
Study Selection
Two independent investigators screened citations for trials of at least 6 months' duration that compared ACE inhibitors, ARBs, or combination therapy with placebo or active control …
引用总数
学术搜索中的文章
WL Baker, CI Coleman, J Kluger, KM Reinhart, R Talati… - Annals of internal medicine, 2009